Win Rutherfurd advises public and pre-IPO companies on capital markets and corporate governance matters and compliance with securities laws. He represents issuers in a range of financing transactions, including equity and debt offerings, liability management, and private placements, including in the area of real estate investment trusts (REITs). Win advises clients on a wide variety of securities laws and governance matters, including drafting and reviewing annual, periodic and current reports and proxy statements, compliance with SEC/stock exchange rules and board meeting minutes, as well as with respect to day-to-day operational matters, including contract review, covenant compliance, internal restructurings, intercompany arrangements, and investor communications.
Intellectual Property (IP) is important for medical technology companies to attract funding and exits, whether M&A or IPO. Learn best practices and pitfalls to avoid in building strategic patent portfolios to close funding, be competitive, and secure an exit. Investors and executives will also discuss how to position a medtech company to attract investors, collaborators, and partners.
Presented By:![]()